Communication Equipment
Compare Stocks
5 / 10Stock Comparison
MITQ vs NCMI vs IMAX vs MVIS vs AVAV
Revenue, margins, valuation, and 5-year total return — side by side.
Advertising Agencies
Entertainment
Hardware, Equipment & Parts
Aerospace & Defense
MITQ vs NCMI vs IMAX vs MVIS vs AVAV — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Communication Equipment | Advertising Agencies | Entertainment | Hardware, Equipment & Parts | Aerospace & Defense |
| Market Cap | $6M | $342M | $1.91B | $205M | $8.40B |
| Revenue (TTM) | $19M | $243M | $405M | $1M | $1.61B |
| Net Income (TTM) | $-275K | $-11M | $43M | $-95M | $-224M |
| Gross Margin | 27.1% | 30.3% | 58.1% | -14.4% | 21.8% |
| Operating Margin | -2.7% | -5.7% | 21.4% | -57.4% | -8.3% |
| Forward P/E | — | — | 20.8x | — | 58.4x |
| Total Debt | $1M | $23M | $297M | $37M | $64M |
| Cash & Equiv. | $6M | $75M | $151M | $32M | $41M |
MITQ vs NCMI vs IMAX vs MVIS vs AVAV — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 21 | May 26 | Return |
|---|---|---|---|
| Moving iMage Techno… (MITQ) | 100 | 16.0 | -84.0% |
| National CineMedia,… (NCMI) | 100 | 10.5 | -89.5% |
| IMAX Corporation (IMAX) | 100 | 218.7 | +118.7% |
| MicroVision, Inc. (MVIS) | 100 | 4.9 | -95.1% |
| AeroVironment, Inc. (AVAV) | 100 | 166.5 | +66.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MITQ vs NCMI vs IMAX vs MVIS vs AVAV
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MITQ plays a supporting role in this comparison — it may shine differently against other peers.
NCMI is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 1.35, Low D/E 5.5%, current ratio 2.42x
- 3.3% yield; 1-year raise streak; the other 4 pay no meaningful dividend
IMAX carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.41
- Rev growth 16.5%, EPS growth 31.3%, 3Y rev CAGR 10.9%
- 16.5% revenue growth vs MVIS's -74.3%
- Lower P/E (20.8x vs 58.4x)
MVIS lags the leaders in this set but could rank higher in a more targeted comparison.
AVAV is the clearest fit if your priority is long-term compounding and defensive.
- 498.7% 10Y total return vs IMAX's 7.9%
- Beta 1.55, current ratio 3.52x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.5% revenue growth vs MVIS's -74.3% | |
| Value | Lower P/E (20.8x vs 58.4x) | |
| Quality / Margins | 10.7% margin vs MVIS's -78.6% | |
| Stability / Safety | Beta 0.41 vs MVIS's 2.66 | |
| Dividends | 3.3% yield; 1-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +36.5% vs MVIS's -41.9% | |
| Efficiency (ROA) | 4.9% ROA vs MVIS's -74.3%, ROIC 12.7% vs -98.3% |
MITQ vs NCMI vs IMAX vs MVIS vs AVAV — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MITQ vs NCMI vs IMAX vs MVIS vs AVAV — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
IMAX leads in 4 of 6 categories
NCMI leads 1 • MITQ leads 0 • MVIS leads 0 • AVAV leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
IMAX leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AVAV is the larger business by revenue, generating $1.6B annually — 1333.0x MVIS's $1M. IMAX is the more profitable business, keeping 10.7% of every revenue dollar as net income compared to MVIS's -78.6%. On growth, AVAV holds the edge at +143.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $19M | $243M | $405M | $1M | $1.6B |
| EBITDAEarnings before interest/tax | -$358,000 | $24M | $150M | -$64M | $82M |
| Net IncomeAfter-tax profit | -$275,000 | -$11M | $43M | -$95M | -$224M |
| Free Cash FlowCash after capex | -$1M | $4M | $115M | -$59M | -$183M |
| Gross MarginGross profit ÷ Revenue | +27.1% | +30.3% | +58.1% | -14.4% | +21.8% |
| Operating MarginEBIT ÷ Revenue | -2.7% | -5.7% | +21.4% | -57.4% | -8.3% |
| Net MarginNet income ÷ Revenue | -1.5% | -4.4% | +10.7% | -78.6% | -13.9% |
| FCF MarginFCF ÷ Revenue | -7.5% | +1.8% | +28.5% | -49.2% | -11.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +10.2% | +7.9% | -6.1% | -86.5% | +143.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +24.8% | +24.0% | +65.5% | +14.3% | -51.5% |
Valuation Metrics
NCMI leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 56.0x trailing earnings, IMAX trades at a 48% valuation discount to AVAV's 108.6x P/E. On an enterprise value basis, NCMI's 12.1x EV/EBITDA is more attractive than AVAV's 103.0x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $6M | $342M | $1.9B | $205M | $8.4B |
| Enterprise ValueMkt cap + debt − cash | $2M | $290M | $2.1B | $209M | $8.4B |
| Trailing P/EPrice ÷ TTM EPS | -6.48x | -33.36x | 56.03x | -1.91x | 108.57x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 20.76x | — | 58.45x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 12.07x | 12.98x | — | 103.03x |
| Price / SalesMarket cap ÷ Revenue | 0.34x | 1.41x | 4.65x | 169.62x | 10.24x |
| Price / BookPrice ÷ Book value/share | 1.27x | 0.84x | 4.58x | 3.29x | 5.35x |
| Price / FCFMarket cap ÷ FCF | 14.11x | 122.26x | 16.03x | — | — |
Profitability & Efficiency
IMAX leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
IMAX delivers a 10.8% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-137 for MVIS. NCMI carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to IMAX's 0.70x. On the Piotroski fundamental quality scale (0–9), NCMI scores 7/9 vs AVAV's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -5.5% | -2.9% | +10.8% | -137.4% | -6.4% |
| ROA (TTM)Return on assets | -20.7% | -2.1% | +4.9% | -74.3% | -5.0% |
| ROICReturn on invested capital | -187.2% | -2.9% | +12.7% | -98.3% | +3.6% |
| ROCEReturn on capital employed | -18.9% | -2.8% | +14.5% | -93.6% | +4.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 7 | 3 | 3 |
| Debt / EquityFinancial leverage | 0.24x | 0.05x | 0.70x | 0.66x | 0.07x |
| Net DebtTotal debt minus cash | -$5M | -$53M | $146M | $4M | $23M |
| Cash & Equiv.Liquid assets | $6M | $75M | $151M | $32M | $41M |
| Total DebtShort + long-term debt | $1M | $23M | $297M | $37M | $64M |
| Interest CoverageEBIT ÷ Interest expense | — | -23.17x | 21.15x | -3.54x | -5.99x |
Total Returns (Dividends Reinvested)
IMAX leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IMAX five years ago would be worth $16,874 today (with dividends reinvested), compared to $258 for MITQ. Over the past 12 months, IMAX leads with a +36.5% total return vs MVIS's -41.9%. The 3-year compound annual growth rate (CAGR) favors IMAX at 21.2% vs MVIS's -34.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -7.2% | -3.6% | -2.0% | -24.9% | -34.3% |
| 1-Year ReturnPast 12 months | +0.3% | -23.4% | +36.5% | -41.9% | -0.1% |
| 3-Year ReturnCumulative with dividends | -35.4% | +25.2% | +77.8% | -71.3% | +63.2% |
| 5-Year ReturnCumulative with dividends | -97.4% | -85.4% | +68.7% | -95.2% | +63.2% |
| 10-Year ReturnCumulative with dividends | -97.4% | -71.0% | +7.9% | -63.3% | +498.7% |
| CAGR (3Y)Annualised 3-year return | -13.6% | +7.8% | +21.2% | -34.0% | +17.7% |
Risk & Volatility
IMAX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
IMAX is the less volatile stock with a 0.41 beta — it tends to amplify market swings less than MVIS's 2.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IMAX currently trades 81.8% from its 52-week high vs MITQ's 37.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.72x | 1.35x | 0.41x | 2.66x | 1.55x |
| 52-Week HighHighest price in past year | $1.66 | $5.56 | $43.16 | $1.73 | $417.86 |
| 52-Week LowLowest price in past year | $0.42 | $2.92 | $24.20 | $0.51 | $159.64 |
| % of 52W HighCurrent price vs 52-week peak | +37.3% | +66.0% | +81.8% | +38.6% | +40.3% |
| RSI (14)Momentum oscillator 0–100 | 52.9 | 63.9 | 42.1 | 44.4 | 37.3 |
| Avg Volume (50D)Average daily shares traded | 259K | 467K | 1.1M | 5.4M | 1.7M |
Analyst Outlook
Evenly matched — NCMI and IMAX each lead in 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: NCMI as "Hold", IMAX as "Buy", MVIS as "Buy", AVAV as "Buy". Consensus price targets imply 647.9% upside for MVIS (target: $5) vs 21.8% for IMAX (target: $43). NCMI is the only dividend payer here at 3.30% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $7.50 | $43.00 | $5.00 | $343.60 |
| # AnalystsCovering analysts | — | 17 | 25 | 7 | 28 |
| Dividend YieldAnnual dividend ÷ price | — | +3.3% | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | 1 | 1 | 0 | — |
| Dividend / ShareAnnual DPS | — | $0.12 | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +6.4% | +0.1% | 0.0% | 0.0% |
IMAX leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NCMI leads in 1 (Valuation Metrics). 1 tied.
MITQ vs NCMI vs IMAX vs MVIS vs AVAV: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MITQ or NCMI or IMAX or MVIS or AVAV a better buy right now?
For growth investors, IMAX Corporation (IMAX) is the stronger pick with 16.
5% revenue growth year-over-year, versus -74. 3% for MicroVision, Inc. (MVIS). IMAX Corporation (IMAX) offers the better valuation at 56. 0x trailing P/E (20. 8x forward), making it the more compelling value choice. Analysts rate IMAX Corporation (IMAX) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MITQ or NCMI or IMAX or MVIS or AVAV?
On trailing P/E, IMAX Corporation (IMAX) is the cheapest at 56.
0x versus AeroVironment, Inc. at 108. 6x. On forward P/E, IMAX Corporation is actually cheaper at 20. 8x.
03Which is the better long-term investment — MITQ or NCMI or IMAX or MVIS or AVAV?
Over the past 5 years, IMAX Corporation (IMAX) delivered a total return of +68.
7%, compared to -97. 4% for Moving iMage Technologies, Inc. (MITQ). Over 10 years, the gap is even starker: AVAV returned +498. 7% versus MITQ's -97. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MITQ or NCMI or IMAX or MVIS or AVAV?
By beta (market sensitivity over 5 years), IMAX Corporation (IMAX) is the lower-risk stock at 0.
41β versus MicroVision, Inc. 's 2. 66β — meaning MVIS is approximately 545% more volatile than IMAX relative to the S&P 500. On balance sheet safety, National CineMedia, Inc. (NCMI) carries a lower debt/equity ratio of 5% versus 70% for IMAX Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — MITQ or NCMI or IMAX or MVIS or AVAV?
By revenue growth (latest reported year), IMAX Corporation (IMAX) is pulling ahead at 16.
5% versus -74. 3% for MicroVision, Inc. (MVIS). On earnings-per-share growth, the picture is similar: National CineMedia, Inc. grew EPS 52. 2% year-over-year, compared to -28. 9% for AeroVironment, Inc.. Over a 3-year CAGR, AVAV leads at 22. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MITQ or NCMI or IMAX or MVIS or AVAV?
IMAX Corporation (IMAX) is the more profitable company, earning 8.
5% net margin versus -78. 6% for MicroVision, Inc. — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IMAX leads at 23. 3% versus -57. 4% for MVIS. At the gross margin level — before operating expenses — IMAX leads at 57. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MITQ or NCMI or IMAX or MVIS or AVAV more undervalued right now?
On forward earnings alone, IMAX Corporation (IMAX) trades at 20.
8x forward P/E versus 58. 4x for AeroVironment, Inc. — 37. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MVIS: 647. 9% to $5. 00.
08Which pays a better dividend — MITQ or NCMI or IMAX or MVIS or AVAV?
In this comparison, NCMI (3.
3% yield) pays a dividend. MITQ, IMAX, MVIS, AVAV do not pay a meaningful dividend and should not be held primarily for income.
09Is MITQ or NCMI or IMAX or MVIS or AVAV better for a retirement portfolio?
For long-horizon retirement investors, IMAX Corporation (IMAX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
41)). MicroVision, Inc. (MVIS) carries a higher beta of 2. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IMAX: +7. 9%, MVIS: -63. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MITQ and NCMI and IMAX and MVIS and AVAV?
These companies operate in different sectors (MITQ (Technology) and NCMI (Communication Services) and IMAX (Communication Services) and MVIS (Technology) and AVAV (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MITQ is a small-cap quality compounder stock; NCMI is a small-cap income-oriented stock; IMAX is a small-cap high-growth stock; MVIS is a small-cap quality compounder stock; AVAV is a small-cap quality compounder stock. NCMI pays a dividend while MITQ, IMAX, MVIS, AVAV do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 5%
- Gross Margin > 18%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.